3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
29
Myelodysplastic Syndromes
10
Advanced Solid Tumors
8
Leukemia, Myelomonocytic, Chronic
6
Myeloproliferative Disorders
5
Advanced Solid Tumor
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Neoplasms
4
Advanced Solid Tumour
4
Multiple Myeloma
3
Lung Neoplasms
3
Leukemia, Monocytic, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumor
2
Small Cell Lung Carcinoma
2
Recurrence
2
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Biphenotypic, Acute
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Malignant Solid Tumor
2
Interventions
Radiosurgery
31
Magnetic Resonance Spectroscopy
16
Temozolomide
12
pembrolizumab
11
Nivolumab
10
Specimen Handling
8
Ipilimumab
8
Bevacizumab
8
Radiotherapy
7
Mental Status and Dementia Tests
7
Memantine
7
abemaciclib
5
Blood Specimen Collection
5
Biopsy
4
trastuzumab deruxtecan
3
entrectinib
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Sodium Chloride
3
Saline Solution
3
Receptors, Interleukin-8B
3
Proton Therapy
3
Dexamethasone
3
Cyclophosphamide
3
trametinib
2
pertuzumab
2
osimertinib
2
fluciclovine F-18
2
contrast agent BR1
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Injections
×
90 days
×
Clear all
No trials found.